Jonathan Licht
Affiliations: | Cancer Center | Icahn School of Medicine at Mount Sinai, New York, NY, United States |
Google:
"Jonathan Licht"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Saintilnord WN, Hegazy YA, Chesnutt K, et al. (2024) Aberrant expression of histone H2B variants reshape chromatin and alter oncogenic gene expression programs. Biorxiv : the Preprint Server For Biology |
| Dupere-Richer D, Riva A, Barwick BG, et al. (2024) KDM6A Regulates Immune Response Genes in Multiple Myeloma. Blood |
| Dupéré-Richer D, Riva A, Maji S, et al. (2024) KDM6A Regulates Immune Response Genes in Multiple Myeloma. Biorxiv : the Preprint Server For Biology |
| de Matos Simoes R, Shirasaki R, Downey-Kopyscinski SL, et al. (2023) Genome-scale functional genomics identify genes preferentially essential for multiple myeloma cells compared to other neoplasias. Nature Cancer. 4: 754-773 |
| Hanley RP, Nie DY, Tabor JR, et al. (2023) Discovery of a Potent and Selective Targeted NSD2 Degrader for the Reduction of H3K36me2. Journal of the American Chemical Society |
| Sriramareddy SN, Faião-Flores F, Emmons MF, et al. (2022) HDAC11 activity contributes to MEK inhibitor escape in uveal melanoma. Cancer Gene Therapy |
| Li J, Hlavka-Zhang J, Shrimp JH, et al. (2021) PRC2 Inhibitors Overcome Glucocorticoid Resistance Driven by NSD2 Mutation in Pediatric Acute Lymphoblastic Leukemia. Cancer Discovery |
| Zee BM, Poels KE, Yao CH, et al. (2021) Combined epigenetic and metabolic treatments overcome differentiation blockade in acute myeloid leukemia. Iscience. 24: 102651 |
| Licht JD, Bennett RL. (2021) Leveraging epigenetics to enhance the efficacy of immunotherapy. Clinical Epigenetics. 13: 115 |
| De Matos Simoes R, Barwick BG, Shirasaki R, et al. (2021) Functional Oncogenomic and Immune Response Landscape for Genes Recurrently Mutated in Myeloma Blood. 138: 1589-1589 |